CX3CL1 and melanoma: While this suggests that some of these recruited monocytes may gain CD16 expression as they differentiate within tumours, we cannot rule out the possibility of the direct recruitment of the non-classical CD16+ monocytes into the tumours, likely via CX3CL1 available in the melanoma TME (Figure 2E).